Literature DB >> 3882287

Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups.

G de Boccardo, D Drayer, A L Rubin, A Novogrodsky, M M Reidenberg, K H Stenzel.   

Abstract

The present study examined the effect of two drugs, which contain either an aromatic amine or hydrazine moiety and are known to induce lupus like syndromes in man (procainamide and hydralazine) and an aliphatic amine (dansylcadaverine), on pokeweed mitogen (PWM)-induced B cell production of immunoglobulin G (IgG). These compounds all inhibited IgG production and generation of IgG plaque forming cells, whereas derivatives of them, without free amine groups, had little or no effect. The compounds inhibited differentiation of B cells to plasma cells, rather than production and secretion of IgG. Mitogen free culture supernatants of peripheral blood mononuclear cells (PBM) activated by the oxidizing mitogen, neuraminidase and galactose oxidase (NAGO), prevented the inhibition of B cell maturation. Moreover, incubation of NAGO treated PBM with hydralazine prevented the production of soluble factors capable of promoting B cell maturation in the presence of hydralazine. We conclude from these studies that procainamide, hydralazine and dansylcadaverine inhibit PWM-induced B cell maturation to plasma cells by an indirect mechanism, via inhibition of production of lymphokines by helper cells. The primary amine or hydrazine group appears to be required for the inhibitory effect, since analogues of the inhibitory compounds, without primary amine groups, are non-inhibitory.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882287      PMCID: PMC1577177     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Transglutaminase activity in human lymphocytes: early activation by phytomitogens.

Authors:  A Novogrodsky; S Quittner; A L Rubin; K H Stenzel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 4.  Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Authors:  H M Perry
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

5.  Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases.

Authors:  E L Dubois
Journal:  Medicine (Baltimore)       Date:  1969-05       Impact factor: 1.889

6.  Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.

Authors:  R L Woosley; D E Drayer; M M Reidenberg; A S Nies; K Carr; J A Oates
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

7.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

8.  Clinical consequences of polymorphic acetylation of basic drugs.

Authors:  D E Drayer; M M Reidenberg
Journal:  Clin Pharmacol Ther       Date:  1977-09       Impact factor: 6.875

9.  A metabolite of 1-hydrazinophthalazine (hydralazine).

Authors:  C D DOUGLASS; R HOGAN
Journal:  Proc Soc Exp Biol Med       Date:  1959-03

10.  Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells.

Authors:  A Novogrodsky; K H Stenzel; A L Rubin
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

View more
  1 in total

1.  Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro.

Authors:  R L Rubin; J T Curnutte
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.